Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$33,436,512
+$7,333,441 QoQ
Shares Held
27,877
-1.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.41%
of 13F equity value
Holder Rank
#670
of 4,605 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 68%
Shared 0%
None 32%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aristotle Atlantic Partners, LLC holds $106,685,535 across 5 Drug Manufacturers - General names. LLY ranks #2 (31.3% of the industry book) .
All Filings in LLY
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,436,512 | 27,877 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $26,103,071 | 28,380 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $30,729,402 | 28,594 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $51,876,370 | 67,990 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $48,712,829 | 62,490 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $35,676,007 | 43,196 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $31,788,644 | 41,177 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $22,652,599 | 25,569 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $20,621,840 | 22,777 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,436,841 | 8,274 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,561,058 | 6,109 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $268,565 | 500 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $234,490 | 500 | Shares | Other | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||